Search results for

According to Regulation 1768/92/EEC supplementary protection certificates (SPCs) can be granted for novel medicines. They are intended to compensate for the reduced effective lifetime of patents covering such medicines.

The Singapore Patents Act was amended on July 1 2004. The amendments have brought about various changes to the search and examination options available to applicants using the PCT route. The options available for applications with filing dates both before and after July 1 2004 are outlined below.

India's Minister for Commerce & Industry has formed a Technical Expert Committee to study two critical issues that Parliament did not consider when it passed the Patents (Amendment) Act 2005. The Expert Committee has been asked to consider the patentability of new chemical entities and micro-organisms. If it suggests that amendments should be made to the law in relation to these two areas, changes will be incorporated into the new legislation.

New rules on criminal thresholds should make it easier for prosecutors to bring charges against IP infringers. But as the authorities struggle to manage a mounting workload, IP owners should consider taking the law into their own hands and launching private criminal prosecutions, explains Gordon Gao

On their face, transfer prices can have dangerous implications for potential damages claims in infringement cases. Phillip Beutel, Bryan Ray and Steven Schwartz outline what in-house counsel need to know to avoid pitfalls

The past year has seen important changes in the EU. It grew from 15 member states to 25 and, for the pharmaceutical industry, many new laws entered into force, were enacted, or were proposed. Linda Horton reviews the developments

On March 1 2005, the China Internet Network Information Center (CNNIC) issued an interpretation on its Domain Name Dispute Resolution Policy (the Interpretation) to clarify three definitions. The Interpretation took immediate effect.

Japanese businesses are increasingly turning to litigation to resolve their IP disputes. Lloyd Parker, Andrew Cobden and Yukihiro Otani spoke to Japanese managers to find out what lies behind the trend

In order to promote pharmaceutical research within the European Community and to keep the pharmaceutical industry from relocating to countries which offer better protection, EC Regulation Number 1768/92 for supplementary protection certificates (SPCs) was created. SPCs in the Netherlands are also governed by Regulation Number 1768/92. This is a clear and simple regulation which was meant to extend the life of a patent as far as it covered a medicinal product which had received regulatory approval and which should have led to harmonized SPC legislation in the European Community.

Last month, I wrote about how the internet has changed the way we practise law. Other technological advancements also have changed the way we practise. In particular, technology has changed the way we conduct discovery in major IP cases and the way we try those cases.